Skip to content

Alcon AG Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: March 3, 2026 results vs estimates

Alcon AG · E.ALC.NYSE · United States
Use symbol E.ALC.NYSE in our API & Excel add-in to retrieve this data ↓
71.13
(+0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 25%
Bubble Risk LOW
Realised Volatility (20D) 28.16%

Alcon AG Forecast

Alcon AG short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is positive (5 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 28.2% a year, a typical one-standard-deviation range is 68.31–73.95 over a week, 65.35–76.91 over a month and 51.10–91.16 over a year. (Signals as of 1 Nov 2026.)

Alcon AG Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
Alcon AG
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Alcon AG
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Alcon AG
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Alcon AG, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Alcon AG

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Alcon AG Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Alcon AG; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Alcon AG’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Alcon AG behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Alcon AG (United States)

Alcon AG is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Alcon AG

Frequently asked questions

What is Alcon AG?
Alcon AG is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Alcon AG price?
The latest close is 71.13 (1 Nov 2026), +0.02% on the day. The price at the top of the page refreshes during the trading day.
Is Alcon AG in an uptrend?
As of 1 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is positive (5 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Alcon AG?
20-day realised volatility is 28.2% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 8.1% over a month and 4.0% over a week.
What factors affect Alcon AG?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Alcon AG, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Alcon AG?
58 backtested tactical asset allocation strategies trade Alcon AG through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Alcon AG returns analysed?
The Statistical Distribution of Returns section shows the distribution of Alcon AG daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Alcon AG historical data?
In the Free historical data section of this page: the last 10 years of Alcon AG daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Alcon AG historical data (last 10 years)

Browse or instantly download the last 10 years of Alcon AG daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.ALC.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2074.31
2026-11-1974.5
2026-11-1875.26
2026-11-1774.11
2026-11-1673.64
2026-11-1374.12
2026-11-1271.83
2026-11-1172.46
2026-11-1074.06
2026-11-0975.14
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.